THE DEFINITIVE GUIDE TO BLOCK PAIN RECEPTORS WITH PROLEVIATE

Possessing identified the palmitoylation motif of APLNR, we intended a short substrate sequence to competitively inhibit the palmitoylation of endogenous APLNR. This competitive peptide, which targets the APLNR palmitoylation site together with morphine, can inhibit the development of NCP, such as pain incidence, microglial activation, and inflamma